Long non-coding RNAs mediate cerebral vascular pathologies after CNS injuries

Neurochem Int. 2021 Sep:148:105102. doi: 10.1016/j.neuint.2021.105102. Epub 2021 Jun 18.

Abstract

Central nervous system (CNS) injuries are one of the leading causes of morbidity and mortality worldwide, accompanied with high medical costs and a decreased quality of life. Brain vascular disorders are involved in the pathological processes of CNS injuries and might play key roles for their recovery and prognosis. Recently, increasing evidence has shown that long non-coding RNAs (lncRNAs), which comprise a very heterogeneous group of non-protein-coding RNAs greater than 200 nucleotides, have emerged as functional mediators in the regulation of vascular homeostasis under pathophysiological conditions. Remarkably, lncRNAs can regulate gene transcription and translation, thus interfering with gene expression and signaling pathways by different mechanisms. Hence, a deeper insight into the function and regulatory mechanisms of lncRNAs following CNS injury, especially cerebrovascular-related lncRNAs, could help in establishing potential therapeutic strategies to improve or inhibit neurological disorders. In this review, we highlight recent advancements in understanding of the role of lncRNAs and their application in mediating cerebrovascular pathologies after CNS injury.

Keywords: Cerebral vascular pathologies; Long non-coding RNAs; Spinal cord injury; Stroke; Therapeutics; Traumatic brain injury.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Animals
  • Brain Injuries, Traumatic / complications
  • Brain Injuries, Traumatic / genetics
  • Central Nervous System / injuries*
  • Cerebrovascular Disorders / etiology*
  • Cerebrovascular Disorders / genetics*
  • Humans
  • RNA, Long Noncoding / genetics*

Substances

  • RNA, Long Noncoding